Burlington-based health care data company Arcadia Healthcare Solutions has raised $30 million from a number of investors, including GE, Blue Cross Blue Shield of Massachusetts and Merck ...

BURLINGTON, Vt. (WCAX) - Vermont is still in the early stages of making available a COVID treatment pill from Merck following an FDA advisory panel’s approval last week of the drug for emergency ...

BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and ...

BURLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), a late-stage biotechnology developing impactful treatments for neuropsychiatric ...

Merck said last week its biggest tariff exposure is through Keytruda and it has enough US inventory for this year. It estimated $200 million in additional costs for the levies implemented to date.